Skip to main content
Premium Trial:

Request an Annual Quote

InforMax, AxCell Finalize Bioinformatics Alliance for Proteomics Database

Premium

PRINCETON, NJ--AxCell Biosciences, a wholly owned subsidiary of Cytogen based here, and InforMax of Rockville, Md., have signed a final agreement to market a proprietary proteomics database that AxCell is developing, as part of an enterprise bioinformatics system to the pharmaceutical, biotechnology, and agricultural industries. As part of the multi-year agreement, InforMax will link AxCell's database to its Software Solution for BioMedicine enterprise bioinformatics system and lead the marketing effort in exchange for a royalty payment on sales. The two companies will initially concentrate on an early-subscriber program for pharmaceutical organizations interested in early access to the data.

Separately, InforMax has launched new versions of its software, Vector NTI Suite 5.5 for desktop sequence analysis and SSBM 2.0, both of which have new features and functions designed to increase productivity of researchers.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.